(Q40077801)

17 September 2017

title

Effect of RNA oligonucleotide targeting Foxo-1 on muscle growth in normal and cancer cachexia mice (English)

1 reference

17 September 2017

C-M Liu

1

1 reference

17 September 2017

Z Yang

2

1 reference

17 September 2017

C-W Liu

3

1 reference

17 September 2017

R Wang

4

1 reference

17 September 2017

P Tien

5

1 reference

17 September 2017

R Dale

6

1 reference

17 September 2017

L-Q Sun

7

1 reference

17 September 2017

publication date

21 September 2007

1 reference

17 September 2017

1 reference

17 September 2017

volume

14

1 reference

17 September 2017

issue

12

1 reference

17 September 2017

page(s)

945-952

1 reference

Therapeutic approaches for muscle wasting disorders

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701091

7 January 2021

Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701091

7 January 2021

Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated Type I (slow twitch/red muscle) fiber genes, and impaired glycemic control

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701091

7 January 2021

FKHR (FOXO1a) is required for myotube fusion of primary mouse myoblasts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701091

7 January 2021

Forkhead transcription factor FKHR-L1 modulates cytokine-dependent transcriptional regulation of p27(KIP1).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701091

7 January 2021

AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701091

7 January 2021

Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701091

7 January 2021

Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701091

7 January 2021

Modulating skeletal muscle mass by postnatal, muscle-specific inactivation of the myostatin gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701091

7 January 2021

Regulation of myostatin activity and muscle growth

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701091

7 January 2021

Lower skeletal muscle mass in male transgenic mice with muscle-specific overexpression of myostatin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701091

7 January 2021

Modulation of myostatin expression during modified muscle use.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701091

7 January 2021

Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701091

7 January 2021

Functional improvement of dystrophic muscle by myostatin blockade.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701091

7 January 2021

Mechanisms involved in the inhibition of myoblast proliferation and differentiation by myostatin.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7701091

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7701091

1 reference

Dimensions Publication ID

17 September 2017

1043763835

0 references

1 reference